Emulate secures $12 mln Series A

Emulate has secured a $12 million Series A financing. Emulate is focused on commercializing Organs-on-Chips to achieve a new standard for mimicking true human physiology so that responses to medicines, chemicals and diseases can be accurately predicted. The Series A was led by NanoDimension with Cedars-Sinai Medical Center and private investor Hansjörg Wyss also participating.

North AmericaUSBriefs